article thumbnail

Diabetes in youth is set to skyrocket in coming decades

STAT

with type 2 diabetes could surge by about 700% over the next four decades, with a greater burden falling on minority groups, a new model predicts. The number of young people in the U.S. Even if the rate of new diagnoses stays constant, there would still be a 70% increase in type 2 cases by 2060. Read the rest…

Diabetes 291
article thumbnail

Vision loss and high cholesterol identified as risk factors for dementia

STAT

These new additions join 12 other risk factors outlined by the commission, affiliated with University College London, in previous reports on dementia prevention, intervention, and care in 2017 and 2020. Read the rest…

Diabetes 363
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: FDA clears first over-the-counter continuous glucose monitor

STAT

    The Stelo product is explicitly designed for people with type 2 diabetes who are not reliant on insulin, or people without diabetes who are curious about how diet and exercise impact their blood sugar levels. The first continuous glucose monitor was approved by the FDA in 2017.

Diabetes 361
article thumbnail

STAT+: Lilly reaches $2.4 million settlement with EEOC over age discrimination lawsuit

STAT

The agreement was disclosed in a consent decree in which Lilly is prevented from rejecting applicants for primary care sales positions in its diabetes and obesity business units based on age. The arrangement will last for 30 months, according to the consent decree filed in a U.S. court in Indianapolis.

Diabetes 243
article thumbnail

STAT+: Pharmalittle: Chinese drugmakers develop copycat weight loss drugs; SEC eyes supplier of research monkeys

STAT

The Chinese companies hope to compete with the Danish pharma group Novo Nordisk’s pioneering drugs in China, which has the world’s largest overweight and diabetic population. If successful, they could also potentially offer a cheaper alternative in the West. And the SEC wants to know whether Inotiv complied with the U.S.

article thumbnail

SAEM Clinical Images Series: A Dangerous Cause of Abdominal Pain

ALiEM - Pharm Pearls

The most common pathogen is Klebsiella pneumoniae, and diabetes mellitus is the most common risk factor. Consider it especially in the patient with abdominal pain with diabetes mellitus. 2017 Mar;78(3 Suppl 2):S28-S31. Additional Images Physical Exam Vitals : BP 172/71; HR 127; T 35.9°C; mmol/L; Glucose 538 mg/dL CRP : 42.6

Diabetes 161
article thumbnail

Sanofi adds BTK inhibitors to pipeline with $3.68bn Principia Biopharma acquisition

pharmaphorum

Sanofi’s acquisition builds on a partnership to develop central nervous system drugs that began in late 2017. In a statement Sanofi said that the acquisition will give it full control of the brain-penetrant BTK inhibitor, SAR442168, making marketing more efficient and eliminating any royalty payments due under the 2017 agreement.

Immunity 124